tweenvest

Bambusa Therapeutics, Inc. (NasdaqGS: BBTX)

Health Care · Biotechnology · US

$15.98

-0.68% today · +6.6% 1Y

Public summary
A free snapshot of Bambusa Therapeutics, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Bambusa Therapeutics, Inc. (NasdaqGS: BBTX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $814.06M and employs 26 people.

Over the last twelve months the share price has gained 6.6%, trading between 14.99 and 17.16.

Tweenvest scores Bambusa Therapeutics, Inc. across four factors: quality 42/100, value 100/100. Its strongest factor is value.

BBTX price history

Oct 30, 2026 · 14.99Weekly closes 14.99 – 16.09Nov 16, 2026 · 15.98

Key figures

Market cap
$814.06M
Revenue (TTM)
—
P/E
-49.37
EPS
-3.96
Dividend yield
—
Beta (5Y)
—
52-week high
$17.16
52-week low
$14.99
Avg volume (3M)
—
Shares outstanding
50.94M
Employees
26
Next earnings
—

About Bambusa Therapeutics, Inc.

Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.

ISIN
US0589371030
Founded
2024
Listed since
Oct 30, 2026
Exchange
Nasdaq Global Select
Currency
USD
CompanyMarket capPriceDay
Syndax Pharmaceuticals, Inc.NasdaqGS: SNDX$858.87M$9.54-0.52%
Seegene, Inc.KOSDAQ: A096530$841.38M₩24,650.00-1.79%
Shaanxi Micot Pharmaceutical Technology Co., Ltd.SEHK: 2335$837.23MHK$19.80-3.79%
City Therapeutics, Inc.NasdaqGM: CTY$827.95M$16.64-4.91%
L&C BIO Co.,LTDKOSDAQ: A290650$813.06M₩20,150.00-6.06%
Aimed Bio Inc.KOSDAQ: A0009K0$802.22M₩16,500.00-9.89%
Rigel Pharmaceuticals, Inc.NasdaqGS: RIGL$800.84M$42.53-1.05%
Ironwood Pharmaceuticals, Inc.NasdaqGS: IRWD$791.33M$4.78-1.85%

Browse every Biotechnology company →